| 1873 |
Management of DR-TB ADR: Vestibular Toxicity |
Pending Review |
18/04/2022 |
| 1849 |
Nodal DR-TB Centre Committee |
Pending Review |
18/04/2022 |
| 247 |
TB Treatment Outcome |
Live |
18/04/2022 |
| 1843 |
Global TB Treatment Outcomes |
Pending Review |
18/04/2022 |
| 1836 |
Reliability of Light Emission Diode [LED] Fluoroscence Microscopy [FM] |
Pending Review |
18/04/2022 |
| 1834 |
Principle of Acid-Fast Bacilli [AFB] Microscopy |
Pending Review |
18/04/2022 |
| 1830 |
Build Pillar of NSP: Digital Information Ecosystem for TB Care |
Pending Review |
18/04/2022 |
| 1826 |
District DR-TB Centre Committee Composition and Functions |
Pending Review |
18/04/2022 |
| 1823 |
Constituents of Monthly Patient-wise Boxes [PWB] for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen |
Pending Review |
18/04/2022 |
| 1820 |
History of Programmatic Management of Drug Resistant TB in India |
Pending Review |
18/04/2022 |
| 1817 |
District DR-TB Centre Committee: Terms of Reference [ToR] |
Pending Review |
18/04/2022 |
| 1815 |
Management of Hepato-toxicity During Treatment with Shorter/Longer Oral MDR-TB Regimen |
Pending Review |
18/04/2022 |
| 1805 |
Preparation of Patient-wise Boxes [PWB] for DR-TB Patients |
Pending Review |
18/04/2022 |
| 1806 |
Distribution of Second-line Drugs from the District Drug Store to the TB Unit Store |
Pending Review |
18/04/2022 |
| 1807 |
H Mono/Poly DR-TB Patient Flow from Diagnosis to Treatment Initiation |
Pending Review |
18/04/2022 |
| 1808 |
Additional Monitoring During Pregnancy and Lactation in Women on Shorter/Longer Oral MDR-TB Regimen |
Pending Review |
18/04/2022 |
| 1804 |
Treatment Algorithm for MDR/RR-TB |
Pending Review |
18/04/2022 |
| 1799 |
Clinical Diagnosis of Drug Resistance/ Probable DR-TB in Children |
Pending Review |
18/04/2022 |
| 1797 |
Patient-centered Care Approach |
Pending Review |
18/04/2022 |
| 1795 |
Factors Affecting the Severity of TB Disease |
Pending Review |
18/04/2022 |
| 1793 |
Screening among Household Contacts of DR-TB Patients |
Pending Review |
18/04/2022 |
| 1791 |
Treatment Regimen for Non-Mycobacterium Tuberculosis [NTM] |
Pending Review |
18/04/2022 |
| 238 |
TB Drug Regimen |
Live |
18/04/2022 |
| 1578 |
Palliative Care in TB patients |
Pending Review |
18/04/2022 |
| 1789 |
Supportive Measures in Palliative Care |
Pending Review |
18/04/2022 |
| 1787 |
Patient Turnaround Time from Identification to Treatment Initiation Relative to the Laboratory Technology Used in DR-TB |
Pending Review |
18/04/2022 |
| 1785 |
Final Treatment Outcomes of DR-TB Cases |
Pending Review |
18/04/2022 |
| 1781 |
Implementation Considerations for Shifting Between Shorter and Longer MDR-TB Regimens |
Pending Review |
18/04/2022 |
| 1779 |
Inventory Management of CBNAAT Cartridges and Truenat Chips |
Pending Review |
18/04/2022 |
| 460 |
The CBNAAT Cartridge |
Live |
18/04/2022 |
